These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39239635)

  • 1. Analysis of miRNAs involved in mouse brain injury upon Coxsackievirus A6 infection.
    Sun Y; Hao Y; Wu J; Qian S; Shen S; Yu Y
    Front Cell Infect Microbiol; 2024; 14():1405689. PubMed ID: 39239635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Pathogenic Properties of Circulating Coxsackievirus A6 Associated with Emerging Hand, Foot, and Mouth Disease.
    Wang SH; Wang A; Liu PP; Zhang WY; Du J; Xu S; Liu GC; Zheng BS; Huan C; Zhao K; Yu XF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of putative novel microRNA expression profiles induced by enterovirus 71 and coxsackievirus A16 infections in human umbilical vein endothelial cells using high-throughput sequencing.
    Song J; Hu Y; Zheng H; Guo L; Huang X; Jiang X; Li W; Li J; Yang Z; Dong S; Liu L
    Infect Genet Evol; 2019 Sep; 73():401-410. PubMed ID: 31176031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profile of human umbilical vein endothelial cells in response to coxsackievirus A10 infection reveals a potential role of miR-143-3p in maintaining the integrity of the blood-brain barrier.
    Hu Y; Cui F; Wang S; Liu C; Zhang S; Wang R; Song J; Zhang Y
    Front Cell Infect Microbiol; 2023; 13():1217984. PubMed ID: 37577373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity and landscape of differential gene expression in mice orally infected with clinical coxsackievirus A6 (CA6).
    Zhang L; Peng W; Wu J; Wei X; Rong N; Zhang G; Yang H; Ding X; Zhao B; Liu J
    J Virol; 2024 Feb; 98(2):e0135823. PubMed ID: 38226810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Evolutionary Dynamics of Coxsackievirus A6 Causing Hand, Foot, and Mouth Disease From 2021 to 2023 in China: Genomic Epidemiology Study.
    Chen Y; Chen S; Shen Y; Li Z; Li X; Zhang Y; Zhang X; Wang F; Jin Y
    JMIR Public Health Surveill; 2024 Jul; 10():e59604. PubMed ID: 39087568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of miRNAs Involved in Mouse Brain Damage upon Enterovirus 71 Infection.
    Yang X; Xie J; Jia L; Liu N; Liang Y; Wu F; Liang B; Li Y; Wang J; Sheng C; Li H; Liu H; Ma Q; Yang C; Du X; Qiu S; Song H
    Front Cell Infect Microbiol; 2017; 7():133. PubMed ID: 28469998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection.
    Lott JP; Liu K; Landry ML; Nix WA; Oberste MS; Bolognia J; King B
    J Am Acad Dermatol; 2013 Nov; 69(5):736-741. PubMed ID: 24035209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul.
    Ceylan AN; Turel O; Gultepe BS; Inan E; Turkmen AV; Doymaz MZ
    Pol J Microbiol; 2019; 68(2):165-171. PubMed ID: 31257789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus A6 2C protein antagonizes IFN-β production through MDA5 and RIG-I depletion.
    Wang S-H; Du J; Yu J; Zhao Y; Wang Y; Hua S; Zhao K
    J Virol; 2023 Nov; 97(11):e0107523. PubMed ID: 37847581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe atypical hand-foot-and-mouth disease in adults due to coxsackievirus A6: Clinical presentation and phylogenesis of CV-A6 strains.
    Broccolo F; Drago F; Ciccarese G; Genoni A; Puggioni A; Rosa GM; Parodi A; Manukyan H; Laassri M; Chumakov K; Toniolo A
    J Clin Virol; 2019 Jan; 110():1-6. PubMed ID: 30472520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of novel microRNAs elicited by EV71 and CA16 infection in human bronchial epithelial cells using high-throughput sequencing.
    Song J; Hu Y; Jiang X; Zhu W; Wu Z; Dong S
    Virus Res; 2018 Mar; 247():111-119. PubMed ID: 29447975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulation of Coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011.
    Lu QB; Zhang XA; Wo Y; Xu HM; Li XJ; Wang XJ; Ding SJ; Chen XD; He C; Liu LJ; Li H; Yang H; Li TY; Liu W; Cao WC
    PLoS One; 2012; 7(12):e52073. PubMed ID: 23272213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of enterovirus 71, coxsackievirus A16 and A6 associated with hand, foot and mouth disease in Spain.
    Cabrerizo M; Tarragó D; Muñoz-Almagro C; Del Amo E; Domínguez-Gil M; Eiros JM; López-Miragaya I; Pérez C; Reina J; Otero A; González I; Echevarría JE; Trallero G
    Clin Microbiol Infect; 2014 Mar; 20(3):O150-6. PubMed ID: 24033818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Coxsackievirus A6 Causing Hand, Foot and Mouth Disease, Vietnam.
    Anh NT; Nhu LNT; Van HMT; Hong NTT; Thanh TT; Hang VTT; Ny NTH; Nguyet LA; Phuong TTL; Nhan LNT; Hung NT; Khanh TH; Tuan HM; Viet HL; Nam NT; Viet DC; Qui PT; Wills B; Sabanathan S; Chau NVV; Thwaites L; Rogier van Doorn H; Thwaites G; Rabaa MA; Van Tan L
    Emerg Infect Dis; 2018 Apr; 24(4):654-662. PubMed ID: 29553326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and epidemiological characteristics of Coxsackievirus A6- and Enterovirus 71-associated clinical stage 2 and 3 severe hand, foot, and mouth disease in Guangxi, Southern China, 2017.
    Ju Y; Tan Z; Huang H; Chen M; Tan Y; Zhang C; Wang J; Wang H; Chen M
    J Infect; 2020 Jan; 80(1):121-142. PubMed ID: 31629866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus a6- and coxsackievirus a10-associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China.
    He YQ; Chen L; Xu WB; Yang H; Wang HZ; Zong WP; Xian HX; Chen HL; Yao XJ; Hu ZL; Luo M; Zhang HL; Ma HW; Cheng JQ; Feng QJ; Zhao DJ
    J Clin Microbiol; 2013 Nov; 51(11):3560-6. PubMed ID: 23966496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
    Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
    Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.